European Archives - Page 20 of 1363 - European Medical Journal

Cyclophosphamide Adds No Benefit in Low-Risk EGPA

A target trial emulation study finds no relapse reduction with cyclophosphamide added to glucocorticoids in eosinophilic granulomatosis with polyangiitis without poor-prognosis factors.

Robot-Based Therapy for Autism Shows Promise

Find out how robot-assisted therapy for autism matches standard treatment outcomes while improving engagement and expanding access in clinical and community settings.

Chemotherapy Linked to Impaired Ovarian Function in New Research

A recent study links chemotherapy to impaired ovarian function and fertility through oxidative damage to ovarian follicles.

Iron Infusion Raises Haemoglobin Before Delivery

Randomised trial shows intravenous iron significantly improves maternal haemoglobin before delivery in non-anaemic iron deficient pregnancy, supporting ferritin screening and targeted treatment in antenatal care.

Novel Antibiotic Provides Symptom Relief in Uncomplicated UTI

Pooled trial data show gepotidacin provides early, meaningful symptom relief comparable to nitrofurantoin in uncomplicated urinary tract infection.

Blood Inflammation Ratio Tied to Diabetic Nephropathy

Meta-analysis shows neutrophil to lymphocyte ratio is associated with higher risk and progression of diabetic nephropathy, supporting its potential use as an inflammatory biomarker in clinical practice.

Biologic Persistence Varies by Prior Exposure in Psoriasis Treatment

Real-world Danish registry data show that biologic drug survival in psoriasis differs between biologic-naive and bioexperienced patients.

Global Perspectives on Cystic Fibrosis: Translating Science into Practice

In this series, host Saranya Ravindran speaks with Stuart Elborn about translating science into practice. They explore pivotal CF trials, novel and…

Fast Five: Caroline Michie on Breast Cancer Updates

In this episode, Caroline Michie discusses key data from ASCENT-3, TROPION2, and PLANeT, and how these findings translate into real-world clinical practice and future decision-making.

UK Trial to Screen 42,000 Patients for Early Liver Disease

A major UK trial launched to screen up to 42,000 adults in primary care for early liver disease using non-invasive testing.